GEN

Verve’s In Vivo Base Editing Therapy Shows Human Proof-of-Concept Data

Verve Therapeutics said Sunday it has generated the first human proof-of-concept data for its in vivo base editing therapy VERVE-101—the first base editing treatment to reach the clinic—in patients ...
Yahoo Finance

GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

HONG KONG, Jan. 5, 2026 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S. Food ...
Lifehacker

Alpha Geek: Video Editing 101

Click to view'Tis the season for sharing home movies—but don't try your friends' and relatives' patience waiting for something good to happen in the hours of tape you shot on vacation. You need to ...
redsharknews.com

RESOLVE EDITING 101 - 01. Setting up and importing media. The definitive tutorial series about video editing with Resolve

No discussion of video editing can now take place without mentioning Blackmagic's DaVinci Resolve. Over the last two years, Blackmagic has added powerful editing features to the highly rated colour ...
Nasdaq

Verve Therapeutics Doses First Human with an Investigational In Vivo Base Editing Medicine, VERVE-101, as a Potential Treatment for Heterozygous Familial Hypercholesterolemia

Phase 1b Clinical Trial, heart-1, Now Underway and Enrolling Patients with Heterozygous Familial Hypercholesterolemia in New Zealand Company Executing VERVE-101 Global Regulatory Strategy with ...
irblog.prnewswire.com

YolTech Announces First Clinical Data from Ongoing Investigator-Initiated Trial of YOLT-101, An In-Vivo Base Editing Therapy for Familial Hypercholesterolemia

SHANGHAI, April 28, 2025 /PRNewswire/ -- YolTech Therapeutics Co.,Ltd, a clinical-stage in vivo gene editing company committed to pioneering the next generation of precision genetic medicines, ...